Search results for "Goals"

showing 10 items of 643 documents

A systematic review on regenerative alveolar graft materials in clinical trials

2021

Abstract Background Alveolar cleft grafting is a necessary procedure to restore bone defects. Randomized clinical trials (RCTs) are regarded as a golden standard for investigating the efficacy of treatments. Nevertheless, risk of bias (RoB) can still affect the validity of these trials. We aimed to conduct a systemic review of all control trials (CTs) using regenerative materials for alveolar cleft reconstructions to evaluate their RoB and perform a meta-analysis of new bone formation. Methods Cochrane Oral Health Group's Trials Register, the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE (PubMed), EMBASE AND Google Scholar were searched up to October 2020. Thereafter, th…

medicine.medical_specialtyEvidence-based medicineMEDLINElaw.inventionIliumRandomized controlled triallawmedicineAdequacy of methodHumansTissue engineeringBone regenerationAutograftsIntention-to-treat analysisbusiness.industryEvidence-based medicineSDG 10 - Reduced InequalitiesRisk of biasJadad scaleSurgeryBone regenerationClinical trialCleft PalateMeta-analysisRegenerative medicine/dk/atira/pure/sustainabledevelopmentgoals/reduced_inequalitiesSurgeryCell transplantationbusinessAlveolar bone graftingJournal of Plastic, Reconstructive and Aesthetic Surgery
researchProduct

Arterial thrombosis in Philadelphia-negative myeloproliferative neoplasms predicts second cancer: a case-control study.

2020

Abstract Patients with Philadelphia-negative myeloproliferative neoplasm (MPN) are prone to the development of second cancers, but the factors associated with these events have been poorly explored. In an international nested case-control study, we recruited 647 patients with carcinoma, nonmelanoma skin cancer, hematological second cancer, and melanoma diagnosed concurrently or after MPN diagnosis. Up to 3 control patients without a history of cancer and matched with each case for center, sex, age at MPN diagnosis, date of diagnosis, and MPN disease duration were included (n = 1234). Cases were comparable to controls for MPN type, driver mutations and cardiovascular risk factors. The freque…

medicine.medical_specialtyImmunologyKaplan-Meier EstimateGene mutationBiochemistryGastroenterologyMyeloproliferative neoplasms03 medical and health sciences0302 clinical medicineSDG 3 - Good Health and Well-beingInternal medicineCarcinomaMedicineHumansPhiladelphia ChromosomeMyeloproliferative neoplasmMyeloproliferative Disordersbusiness.industryCase-control studyCancerfood and beveragesMyeloproliferative neoplasmssecond cancersarterial eventsNeoplasms Second PrimaryThrombosisCell BiologyHematologyOdds ratioArteriesmedicine.diseasesecond cancersThrombosisSettore MED/15 - MALATTIE DEL SANGUEarterial events030220 oncology & carcinogenesisCase-Control StudiesMultivariate Analysis/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingSkin cancerbusiness030215 immunologyFollow-Up StudiesBlood
researchProduct

Oral leukoplakia: the ongoing discussion on definition and terminology

2015

In the past decades several definitions of oral leukoplakia have been proposed, the last one, being authorized by the World Health Organization (WHO), dating from 2005. In the present treatise an adjustment of that definition and the 1978 WHO definition is suggested, being : “A predominantly white patch or plaque that cannot be characterized clinically or pathologically as any other disorder; oral leukoplakia carries an increased risk of cancer development either in or close to the area of the leukoplakia or elsewhere in the oral cavity or the head-and-neck region”. Furthermore, the use of strict diagnostic criteria is recommended for predominantly white lesions for which a causative factor…

medicine.medical_specialtyKeratosisDentistryOdontologíaReviewOral cavityTerminologyLesionstomatognathic systemSDG 3 - Good Health and Well-beingTerminology as TopicmedicineHumansGeneral DentistryLeukoplakiaOral Medicine and Pathologybusiness.industryDecision Treesmedicine.disease:CIENCIAS MÉDICAS [UNESCO]DermatologyCiencias de la saludOral leukoplakiastomatognathic diseasesIncreased riskOtorhinolaryngologyUNESCO::CIENCIAS MÉDICAS/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingSurgeryCancer developmentmedicine.symptomLeukoplakia Oralbusiness
researchProduct

How general dentists could manage a patient with oral lichen planus

2018

Background The literature hardly contains information on how patients suffering from oral lichen planus could be managed by dentists. Material and Methods Based on the limited available literature and particularly on the long-term clinical and histopathological experience of one of the authors, suggestions on how dentists could manage patients with oral lichen planus have been put forward. Results: In most cases, the dentist should be able to establish a correct diagnosis. Results In most cases, the dentist should be able to establish a correct diagnosis. Occasionally, the dentist may call upon a specialist, usually an oral medicine specialist or an oral and maxillofacial surgeon for confir…

medicine.medical_specialtyMEDLINEOral Medicine SpecialistReview03 medical and health sciences0302 clinical medicinestomatognathic systemSDG 3 - Good Health and Well-beingPatient informationmedicineHumansOral Diagnosisskin and connective tissue diseasesGeneral DentistryBiopsy procedureOral therapyOral Medicine and Pathologyintegumentary systembusiness.industryGeneral surgery030206 dentistrymedicine.disease:CIENCIAS MÉDICAS [UNESCO]stomatognathic diseasesOtorhinolaryngology030220 oncology & carcinogenesisGeneral practiceUNESCO::CIENCIAS MÉDICASGeneral Practice Dental/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingSurgeryOral lichen planusbusinessLichen Planus Oral
researchProduct

A clinical diagnosis of oral leukoplakia: A guide for dentists

2017

Background In view of the many white or predominantly white lesions of the oral mucosa it is a challenge for dentists to clinically identify a leukoplakia, being a potentially (pre)malignant lesion. Material and Methods Based on the available literature and experience of the authors the parameters of a clinical diagnosis of oral leukoplakia have been studied. Results A guide has been presented that should help dentists to establish a clinical diagnosis of leukoplakia as accurate as possible. Conclusions Probably in most parts of the world dentists will need the help of a specialist for confirmation or exclusion of the clinical diagnosis of oral leukoplakia and for further management of the …

medicine.medical_specialtyMEDLINEReview03 medical and health sciences0302 clinical medicinestomatognathic systemPatient informationmedicineHumansOral DiagnosisOral mucosaGeneral DentistryLeukoplakiaOral Medicine and Pathologybusiness.industry030206 dentistryBenign lesionSDG 10 - Reduced Inequalities:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseDermatologyOral leukoplakiastomatognathic diseasesmedicine.anatomical_structureOtorhinolaryngologyDentistry030220 oncology & carcinogenesisClinical diagnosisPractice Guidelines as TopicUNESCO::CIENCIAS MÉDICAS/dk/atira/pure/sustainabledevelopmentgoals/reduced_inequalitiesSurgeryLeukoplakia Oralbusiness
researchProduct

Effects of diet-induced obesity and voluntary wheel running on the microstructure of the murine distal femur

2011

Abstract Background Obesity and osteoporosis, two possibly related conditions, are rapidly expanding health concerns in modern society. Both of them are associated with sedentary life style and nutrition. To investigate the effects of diet-induced obesity and voluntary physical activity we used high resolution micro-computed tomography (μCT) together with peripheral quantitative computed tomography (pQCT) to examine the microstructure of the distal femoral metaphysis in mice. Methods Forty 7-week-old male C57BL/6J mice were assigned to 4 groups: control (C), control + running (CR), high-fat diet (HF), and high-fat diet + running (HFR). After a 21-week intervention, all the mice were sacrifi…

medicine.medical_specialtyPathologyEndocrinology Diabetes and MetabolismOsteoporosisMedicine (miscellaneous)lcsh:TX341-641Clinical nutritionDistal femurSDG 3 - Good Health and Well-beingFemoral metaphysisInternal medicinemedicineQuantitative computed tomographylcsh:RC620-627Nutrition and Dieteticsmedicine.diagnostic_testbusiness.industryResearchmedicine.diseaseObesitylcsh:Nutritional diseases. Deficiency diseasesEndocrinologyWheel runningSedentary life style/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingbusinesslcsh:Nutrition. Foods and food supplyNutrition & Metabolism
researchProduct

Birth Weight and Diabetic Retinopathy: Results From the Population-Based Gutenberg Health Study (GHS).

2020

Purpose: This study investigates the relationship between diabetic retinopathy (DR) and birth weight (BW) in diabetic subjects sampled from the general population. Methods: The Gutenberg Health Study (GHS) is a population-based, observational cohort study in participants aged from 35 to 74 years. Criteria for diabetes diagnosis were HbA1c ≥6.5% at study entry, a doctor-diagnosis of diabetes, or diabetes medication. The presence of DR was determined by evaluating fundus photographs. BW was assessed by self-reports. GHS participants were divided into three different BW groups (low: <2500 g; normal: 2500–4000 g; high:>4000 g). Logistic regression analysis was conducted as uni- and multiv…

medicine.medical_specialtyPediatricsEpidemiologyBirth weightPopulation basedCohort Studies03 medical and health sciences0302 clinical medicineSDG 3 - Good Health and Well-beingRisk FactorsDiabetes mellitusEpidemiologymedicinePrevalenceBirth WeightHumans030212 general & internal medicineGlycated HemoglobinDiabetic Retinopathybusiness.industryDiabetic retinopathymedicine.diseasePopulation based studyOphthalmologyCross-Sectional StudiesDiabetes Mellitus Type 2030221 ophthalmology & optometry/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingbusinesshormones hormone substitutes and hormone antagonistsOphthalmic epidemiology
researchProduct

Are we able to reduce the mortality and morbidity of oral cancer; Some considerations

2012

Oral cancer makes up 1%-2% of all cancers that may arise in the body. The majority of oral cancers consists of squamous cell carcinomas. Oral cancer carries a considerable mortality rate, being mainly dependent on the stage of the disease at admission. Worldwide some 50% of the patients with oral cancer present with advanced disease. There are several ways of trying to diagnose oral cancer in a lower tumor stage, being 1) mass screening or screening in selected patients, 2) reduction of patients’ delay, and 3) reduction of doctors’ delay. Oral cancer population-based screening (“mass screening”) programs do not meet the guidelines for a successful outcome. There may be some benefit when foc…

medicine.medical_specialtyPopulationOdontologíaDiseaseSDG 3 - Good Health and Well-beingHumansMedicineRisk factorIntensive care medicineeducationGeneral DentistrySurvival rateEarly Detection of CancerMass screeningMouth neoplasmeducation.field_of_studyOral Medicine and Pathologybusiness.industryMortality rateReview-ArticleCancer:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseCiencias de la saludSurgeryOtorhinolaryngologyUNESCO::CIENCIAS MÉDICAS/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingMouth NeoplasmsSurgerybusiness
researchProduct

Oral potentially malignant disorders: is malignant transformation predictable and preventable?

2014

Leukoplakia is the most common potentially malignant disorder of the oral mucosa. The prevalence is approximately 1% while the annual malignant transformation ranges from 2% to 3%. At present, there are no reliable clinicopathological or molecular predicting factors of malignant transformation that can be used in an individual patient and such event can not truly be prevented. Furthermore, follow-up programs are of questionable value in this respect. Cessation of smoking habits may result in regression or even disappearance of the leukoplakia and will diminish the risk of cancer development either at the site of the leukoplakia or elsewhere in the mouth or the upper aerodigestive tract. The…

medicine.medical_specialtyReferralOdontologíaReviewMalignant transformationSDG 3 - Good Health and Well-beingstomatognathic systemPredictive Value of TestsOral and maxillofacial pathologymedicineHumansOral mucosaGeneral DentistryLeukoplakiaOral Medicine and Pathologybusiness.industrymedicine.disease:CIENCIAS MÉDICAS [UNESCO]DermatologyCiencias de la saludSurgerystomatognathic diseasesmedicine.anatomical_structureCell Transformation NeoplasticOtorhinolaryngologyPredictive value of testsUNESCO::CIENCIAS MÉDICAS/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingSurgeryOral lichen planusMouth NeoplasmsCancer developmentLeukoplakia OralbusinessLichen Planus OralMedicina Oral Patologia Oral y Cirurgia Bucal
researchProduct

Characterising individual response to mepolizumab treatment

2020

Background: Patients with severe eosinophilic asthma (SEA) often have heterogenous phenotypes with periods of asthma worsening, making it difficult to assess mepolizumab treatment response. Aims: To define patient level variables for mepolizumab treatment response. Methods: In this post-hoc analysis we examined mepolizumab response in patients with SEA (≥2 exacerbations in prior year) in the 32-week, randomised, placebo-controlled MENSA study and the following 52-week, open-label COSMOS study. Patients who completed both studies and received mepolizumab throughout were included (n=311). Results: In MENSA, 67% and 21% of patients had 0 or 1 exacerbations, respectively, and were considered re…

medicine.medical_specialtyTreatment responseExacerbationbusiness.industryEosinophilic asthmaTreatment goalsmedicine.diseaseInternal medicinemedicineIn patientbusinessMepolizumabAsthmamedicine.drugAirway pharmacology and treatment
researchProduct